OTCPicks.com

FEATURED COMPANY

ANGSTROM MICROSYSTEMS CORPORATION (OTCBB: AGMS)

Detailed Quote: www.otcpicks.com/quotes/AGMS.php

Company Profile:
http://www.otcpicks.com/angstrom-microsystems/angstrom-microsystems.htm

Angstrom Microsystems is one of the top Green computing companies, providing technology solutions ranging from liquid-cooled blades to acceleration software in order to help reduce the power requirements of datacenters. Its customers include Rhythm & Hues, Fox Films, Tippett Studios and the National Institutes of Health. Angstrom has earned a reputation for quality, service, and engineering innovation in the AMD Opteron processor-based system market. See Angstrom Microsystems in the end credits of Blue Sky Studios' "Ice Age: The Meltdown."

AGMS News:

August 27 - Gartner Research Says Global Server Shipments Grew 12% in Q2, 2008

Angstrom Is Aggressively Pursuing Server Market Share

Angstrom Microsystems Corp. (OTCBB: AGMS) is leading the market in "Green Computing" solutions. Angstrom is focused on providing "Green Computing" solutions to help clients reduce their carbon footprint while saving energy and saving them money over traditional computing solutions.

According to Gartner, Inc., "Worldwide server shipments for the second quarter of 2008 increased 12.2 percent over the same quarter last year, while worldwide server revenue for the same period climbed 5.7 percent. Worldwide server revenue totaled $13.8 billion for the second quarter, as worldwide servers shipments reached 2.3 million units."

"In spite of economic constraints in some markets like the United States, on a worldwide basis, servers continued to grow in the second quarter of the year," said Jeffrey Hewitt, research Vice President at Gartner. "The most significant driver in the quarter continued to be an upswing in x86 server replacements that started in the first quarter. This, coupled with Web data center build outs and growth in emerging markets, produced solid Q2 results."

Lalit Jain, CEO of Angstrom Microsystems, said, "We have some solid companies in the blade server market competing against the likes of HP, Dell and IBM. We are, however, differentiating ourselves from our competition through our use of energy saving technologies, energy efficient Quad-Core AMD Opteron™ processor-based blade servers, and our unique software acceleration libraries." Mr. Jain adds, "At the end of the day Angstrom can do it better, faster and cheaper than our large competitors in the market. Just 1% of the global market would represent 23,000 units per quarter. I think we are competitively positioned with our software and hardware technologies to go after a decent sized piece of the blade server market. While the overall economy is struggling, the server market is growing and we like our chances in gaining market share against our major market competitors."

FEATURED COMPANY

INDUSTRIAL BIOTECHNOLOGY CORPORATION (OTC: IBOT)
"Up 4.46% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/IBOT.php

Company Profile:
http://www.otcpicks.com/industrial-biotech/industrial-biotech-2.htm

Industrial Biotechnology Corporation, (IBC) provides products, services and technologies using renewable resources as an alternative to petroleum and traditional manufacturing methods. IBC production processes are eco-efficient and apply and adhere to sustainable practices and standards. IBC accomplishes this with the ALCHEMx Production Platforms™, which integrates technologies, sustainable manufacturing, and distribution with supply chain partners to meet customer needs and pricing requirements. IBC utilizes sugarcane based ethanol which is considered the leading cost efficient, energy balanced and environmentally sustainable feedstock source, when compared to petroleum and other alternative fuels.

IBOT News:

August 27 - Industrial Biotechnology Corporation Announces VP of Investor and Public Relations

Company Highlighted in BIOMASS Magazine

Industrial Biotechnology Corporation (OTC: IBOT) (IBC) announced the appointment of Craig McClure as VP of Investor and Public Relations. Mr. McClure has over 20 years in the investment services industry working as a licensed professional with companies such as Wachovia Securities, Aegon NV and LaSalle St. Securities.

“I am very pleased to join Industrial Biotechnology Corporation. Economic conditions, environmental concerns and the efficient use of the planet's food resources have placed sugar cane based ethanol at the forefront of efficient petroleum alternatives. Our current coverage in BIOMASS Magazine is indicative of the Industry interest we are receiving. Eco-efficient sugarcane ethanol used as both a petrochemical and fuel alternative makes the most sense economically and for the environment,“ said Craig McClure, IBC VP of Investor and Public Relations.

BIOMASS Magazine is produced by BBI Media, the world leader in biofuels/biomass industry publishing. They also publish Ethanol Producer Magazine and Biodiesel Magazine as well as offering an ever expanding line of online services. A copy of the article can be viewed here: BIOMASS Magazine September, 2008.

FEATURED COMPANY

SPONGETECH DELIVERY SYSTEMS (OTCBB: SPNG)

Detailed Quote: http://www.otcpicks.com/quotes/SPNG.php

Company Profile: http://www.otcpicks.com/spongetech/spongetech.htm

SpongeTech Delivery Systems is a development stage company which designs, produces, markets and distributes cleaning products for vehicular use utilizing patented technology relating to sponges containing hydrophilic (liquid absorbing) foam polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, which is loaded with specially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.

SPNG News:

August 26 - SpongeTech® Delivery Systems, Inc. Sponsored Darryl Strawberry Foundation's 2nd Annual Charity Golf Classic

Sports Greats and Celebrities Take a Swing Against Developmental Disorder to Support Foundation for Children and Families Affected by Autism

SpongeTech Delivery Systems, Inc. (OTCBB: SPNG) (www.spongetech.com) a company which designs, produces, and markets innovative, cost-effective, and environmentally sensitive packaging and product delivery solutions through its exclusive patented packaging technology, sponsored the Darryl Strawberry Foundation Golf Outing for Children and Families Affected by Autism on Monday, August 25th at the Bethpage State Park in Farmingdale, New York.

Among the sports greats in attendance were: Carl Banks, Sam Rosen, John Starks, Willie Upshaw, Ozzie Smith, Ray Lucas, Curtis McGriff, Bruce Harper, and Ron Darling, among others.

SpongeTech has a partnership with the Darryl Strawberry Foundation whereby the Company has committed to donate a percentage of its children's bath sponge, Puddle Pals, revenues to the Darryl Strawberry Foundation. Puddle Pals is a baby bath toy filled with hypoallergenic soap, with each sponge capable of up to eight washes.

"We were pleased to be a part of an event to support such an important cause," said Steven Moskowitz, COO of SpongeTech. "We believe our technologies have great potential to grow in popularity as we continue to market and promote SpongeTech's products. We look forward to continuing to support this foundation and to participate in other marketing opportunities as our company remains on track for future growth."

FEATURED COMPANY

CELEBDIRECT INCORPORATED (OTC: CELI)

Detailed Quote: http://www.otcpicks.com/quotes/CELI.php

Company Profile: http://www.otcpicks.com/celebdirect/celebdirect-2.htm

CelebDirect's primary business is that of a direct response celebrity incubator and has two divisions which are direct response marketing and Celebrity placement / franchise opportunities. CelebDirect brings to the market unique and innovative products via direct to market strategies such as infomercials, advertorials and other associated advertising vehicles to expeditiously, economically and broadly market products throughout North American as well as a global basis. CelebDirect has a number of consumer-oriented products it is evaluating and others it is currently bringing to market.

CELI News:

August 26 - CelebDirect Releases a New Corporate Flash Profile and Audio Interview with CEO Danny Alex Featured on Smallcapengine.com

CelebDirect (OTC: CELI) has announced that it is using Smallcapengine.com (www.Smallcapengine.com) to help with its marketing efforts via this new informative Flash Presentation/Profile/Audio Interview. The profile can be viewed in this link:

http://smallcapengine.com/company_profiles_view.aspx?id=143

FEATURED COMPANY

NEXPLORE CORPORATION (OTC: NXPC)

Detailed Quote: www.otcpicks.com/quotes/NXPC.php

Company Profile: www.otcpicks.com/nexplore/nexplore.htm

NeXplore Technologies is developing a Web 2.0 search engine and an assortment of social networking portals and tools that will enable users to personalize their Web experience and tailor it to their unique needs, interests, and online pursuits. The Company’s social computing platform, MyCircle.com, offers an enhanced, user-friendly graphical interface search engine, combined with innovative backend technology, which enables users to improve the way they connect with information and other people on the Worldwide Web. MyCircle’s Web 2.0 interface provides users with an online tool for sharing their Blogs, Voice-Over IP, photos and documents, podcasts and videocasts, classified advertising, instant messages, SMS text messages, Chat and personal profiles.

NXPC News:

August 23 - Growing Popularity, Ubiquitous Broadband to Change the Face of Internet Search

NeXplore CMO Scott Grizzle: "Search Needs a Facelift"

A recent survey conducted by PEW Internet & American Life Project (PIP) reveals that "almost half of all Internet users now use search engines on a typical day," an increase of 69% from 2002 when Pew Internet & American Life Project first tracked search activity. The PIP survey also finds that those who use broadband connections at home are "significantly more likely" to use search than those with a dialup connection.

According to Scott Grizzle, chief marketing officer for NeXplore Corporation (OTC: NXPC), search's growing popularity and the proliferation of broadband will drive dramatic changes in the Internet search experience, particularly in how consumers interact with search engine results pages (SERPs).

Grizzle said, "Ubiquitous broadband has conditioned consumers to expect a more dynamic and engaging Internet experience. The search experience, for the most part, has not kept pace with the rest of the Internet. The days of serving up line after line of static text results are coming to an end. As popularity, familiarity and proficiency with Internet search grows, consumers will demand that search results pages have more video presentation and rich-media interaction, less drill down and deeper personalization. There's no question, Internet search is long overdue for a facelift."

For its part, NeXplore Corporation recently launched NeXplore Search (www.NeXplore.com), an innovative Web 2.0 search engine optimized for a superior end-user experience, rich-media display and social network integration. Currently open for public beta, NeXplore Search had more than one million unique visitors in both May and June of 2008 according to web-analytics company Compete.com.

FEATURED COMPANY

QUOTEMEDIA INCORPORATED (OTCBB: QMCI)
"Up 9.09% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/QMCI.php

Company Profile: http://www.otcpicks.com/quotemedia/quotemedia.htm

QuoteMedia, Inc. is a leading software developer and provider of real-time streaming financial market information, decision-support, news and research solutions to brokerage, financial services companies, business and media corporations. Among its many leading-edge products lines, the Company offers data feeds, news, dynamic market content solutions, interactive stock research tools, financial applications and real-time wireless applications. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Forbes.com, Scotia Capital, Business Wire, Southwest Securities, Regal Securities, FBR Direct, Broadridge Financial Solutions, Inc., AIM Trimark, Zacks Investment Research, ChoiceTrade, QTrade, Schaeffer's Investment Research, Automated Financial Systems, WallStreet*E, and others. For more information, visit www.quotemedia.com.

QMCI News:

August 14 - QuoteMedia Reports 30% Increase in Revenue for Q2 2008

QuoteMedia, Inc. (OTCBB: QMCI), a leading provider of market data and financial applications, announced financial results for the three and six months ended June 30, 2008. These results reflect a 30% increase in second quarter revenues, to $1,724,396 from $1,331,405 in the comparative period in 2007. Revenue for the six months ended June 30, 2008 increased 37%, to $3,412,071 from $2,492,105 in the comparative period in 2007. At June 30, 2008 the Company’s cash balance was $463,214, an increase of $105,898 from the balance at December 31, 2007. Net cash provided by operating activities was $377,428 for the six months ended June 30, 2008; this represents an $875,428 increase in cash generated from operations, when compared to the $598,000 that was used in operating activities in the comparative period.

“The significant revenue growth during the quarter resulted from increased sales of our Interactive Content and Data Applications as well as from increased subscriptions to our Quotestream product line,” says Keith Guelpa, president of QuoteMedia, Inc. “This is our 21st consecutive quarter of revenue growth, reflecting the strong continuing market penetration of our full line of financial data products and the increasing depth of our data offerings, which now cover over 70 exchanges worldwide.

“During the second quarter, QuoteMedia continued to build on the revenue growth momentum that has been building since 2007. We furthered our introduction of Quotestream II to the market, the new generation of our portfolio management system, with enhanced features and functionality. The Company also continued its early release of Quotestream Professional. Where Quotestream II is geared towards providing a professional level experience to non-professional users, Quotestream Professional is designed specifically for use by financial services professionals, offering unparalleled functionality at extremely aggressive pricing.

“Our second quarter was also significant in that much of the groundwork was laid for developments that are coming to fruition now. One example is our announcement earlier this week of our enterprise agreement with Penson Worldwide Inc. Penson is a global provider of execution, clearing, custody, settlement and technology infrastructure products to the financial services sector. Under this agreement Penson will integrate QuoteMedia offerings into platforms that it provides to its nearly 300 correspondent financial services firms. As well, Penson will offer its clients Quotestream Pro and Quotestream II. Also, earlier this month we announced that Mr. James Kelly joined the Company. He is a senior sales executive who brings a wealth of knowledge and successful experience to QuoteMedia, particularly in the financial services professional market to which Quotestream Professional is targeted. Mr. Kelly joins Mr. George Katsch in our New York office. Founded on marketing developments such as these and others, and our performance record, we expect that our customer base will continue to expand dramatically and that our trend of strong revenue increases, quarter over quarter, will continue into the foreseeable future.

“We remain focused on our revenue growing strategies,” says Guelpa. “Our plan of operation for the remainder of 2008 continues to focus on marketing Quotestream II for deployments by brokerage firms to their clients, and moving with increasing strength into the investment professional market with Quotestream Professional. We also plan to continue the market penetration of our Data Feed Services, which is a particularly fertile segment of our product line. We will also continue to license our Quotestream Wireless applications and add new data content to expand our line of Interactive Content and Data Applications.”

“As previously forecasted, and consistent with our focus on expansion, we experienced a loss for the quarter of $360,758 compared to a loss of $424,902 in the comparative period. For the six months ended June 30, 2008 we incurred a loss of $715,677 compared to a loss of $796,987 in the comparative period. While we expect that we will continue to incur losses in the short term, we expect our monthly revenues will continue to rise significantly in 2008 and overtake the increased cost commitments that we have undertaken to support our rapid development. Our improvement in gross margin rates to 57% reflects the stabilization of our fixed cost structures while revenues continue to increase. We expect our costs of revenue to continue to reduce as a percentage of revenues generated. We are very pleased with our progress to date, and we believe that we are on target to meet our near and long term objectives,” says Guelpa.

STOCKS TO WATCH

MONARCH STAFFING INCORPORATED (OTC: MSTF)
"Up 20.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MSTF.php

Monarch Staffing, Inc., through its subsidiaries, provides healthcare staffing services to commercial and government sector customers in the United States. It furnishes personnel to perform a range of pharmacy technician, nursing, and other health care services in support of the operations of government and commercial facilities. The company is based in Irvin, California.

MSTF News:

August 25 - Monarch Staffing, Inc. Launches Nurse Consultants to Build Its Nurse Staffing Business

New Operating Division Will Be Led by Industry Veteran and Based in Fresno

Monarch Staffing, Inc. (OTC: MSTF), and its wholly owned subsidiary Drug Consultants, Inc., a provider of healthcare staffing services, announced the launch of Nurse Consultants, a new operating division focused on the nurse staffing business.

Nurse Consultants will be lead by Edwina Chong, Executive Vice President, a nurse staffing industry veteran. Prior to joining Drug Consultants, Inc., Ms. Chong built one of the largest local nursing recruitment and staffing firms in the country. From 2001 to 2007, she was Area Manager with Supplemental Health Care where she grew annualized revenues in excess of $21 million. "I am extremely excited to lead the growth of our new operating division," commented Ms. Chong.

Nurse Consultants has opened a new office in Fresno, CA to house its sales & marketing, recruiting and scheduling operations.

"The launch of Nurse Consultants and the opening of a new operating office in Fresno advances our plan to penetrate the growing nurse staffing business. Additionally, we expect the launch will help diversify Monarch Staffing's service offerings and customer base," commented David Walters, Chairman.

DEMATCO INCORPORATED (OTCBB: DMAT)
"Up 43.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/DMAT.php

DeMatco, Inc. provides proprietary dematerialization services to the securities industry primarily in the United Kingdom. It converts financial instruments from paper form to electronic form so as to enable such instruments to be traded electronically on exchanges or exchange platforms on a peer to peer basis. The company was founded in 2005 and is based in Encino, California.

DMAT News:

August 26 - Dematco, Inc. Announces Another European Investor Group to Dematerialize More Senior Life Settlement Policies Through Dematco, Ltd.

Dematco, Inc. (OTCBB: DMAT) announced that its wholly-owned subsidiary Dematco, Ltd. has been engaged by another leading European investor group to dematerialize more Senior Life Settlement Units (SLSU) from Senior Life Settlement policies. Dematco, Ltd. converts all manner of paper instruments into electronically transferable units; and for this their second contract the Company received an initial stage payment of $75,000. A $30,000,000 face value project, Dematco expects to receive $525,000 in payment for services upon completion of the dematerialization. The units will be traded through Private Trading Systems PLC (PlusMarkets:PTSP), a proprietary trading and clearing system. The Company has a working business relationship with Private Trading Systems.

Robert Stevens, Chairman of Dematco, Inc. comments, "Signing our second contract in just two weeks, we appear to be well positioned in this underserved market. Our dematerialization process seems to be the product the investor groups want. We expect to announce more agreements that significantly grow our client base impacting our expanding revenues.”

GOOD LIFE CHINA CORPORATION (OTC: GLCC)
"Up 20.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/GLCC.php

Good Life China Corporation operates a chain of franchised convenience stores in Hebei Province, the People’s Republic of China. The company employs retail concepts, such as e-commerce enabled POS/back office systems. It operates approximately 1,730 stores. The company also has an agreement with Petro China Beijing to provide distribution services and information management system services for the convenience stores in the gas stations belonging to Petro China Beijing Marketing Company. In addition, the company offers online sub prime financial services, such as money lending, forex trading, and advanced electronic funds management. Good Life China Corporation was incorporated in 1998 and is based in Toronto, Canada.

GLCC News:

August 28 - Good Life China To Acquire An Agriculture Company

Good Life China Corporation (OTC: GLCC) (www.goodlifechina.com) announced that it has signed a Letter of Intent to acquire a second Chinese based company of similar size and financial stature to Good Life's current operations. The company is in the agriculture business, with revenues in the 5-6 million dollar range and assets of about 10-14 million dollars. The purchase price consists of cash and restricted stock.

The parties are beginning the due diligence process which they expect to complete within the next 60-90 days.

Based on a successful acquisition, GLCC will be looking at the option of uplifting itself and or the targeted acquisition Company to the OTCBB, in line with previous announcements and filings made by the Company. This will require auditing of the respective financial statements of the two companies, and a thorough review of other disclosure requirements including compliance with some aspects of Sorbanes Oxley.

Additional announcements will be made as the negotiations move forward, either through news worthy updates or update notices filings on Pink Sheets.

ORIGIN AGRITECH LIMITED (NASDAQ: SEED)
"Up 22.35% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/SEED.php

Origin Agritech Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of hybrid crop seeds in the People's Republic of China. It primarily offers four products: corn, rice, cotton, and canola. The company also develops, produces, and sells both internally developed and licensed crop seeds. Origin Agritech distributes its products through a distribution network, including first-level distributors, second-level distributors, and retailers. It sells a majority of its seeds developed and produced under license agreements with the Corn Research Institute of Li County, Shijiazhuang Liyu Technology Development Co., Ltd., and the Henan Agricultural University. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

SEED News:

August 27 - Origin Agritech Limited Reports Third Quarter FY08 Results

* Revenues increased 7.73% to RMB 490.71 million from RMB 455.49 million
* Gross profit rose 32.29% to RMB 144.09 million from RMB 108.92 million
* Income from Operations rose 65.77% to RMB 98.38 million from 59.35 million
* Net income increased 62.98% to RMB 60.12 million from RMB 36.89 million
* Fully diluted EPS increased 74.67% to RMB 2.62 from RMB 1.50

Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a technology-focused supplier of crop seeds in China, announced unaudited financial results for the third quarter ended June 30, 2008. Origin prepares its financial statements in accordance with generally accepted accounting principles (GAAP) of the United States.

Financial Results Overview:

During the third quarter of fiscal 2008, the Company generated revenues of RMB 490.71 million (US$71.54 million), an increase of 7.73% from revenue of RMB 455.49 million (US$59.84 million) for the three months ended June 30, 2007. This was mainly due to a 6.2% increase in the average sales price of our products across all seed types with volumes also increasing 2.2%.

Corn revenues increased 7.75% year-over-year to RMB 366.04 million (US$53.37 million) from RMB 339.72 million (US$44.63 million). This was mainly due to a 10.25% increase in the average sales price of our products across corn seed types.

Gross margins for the third quarter improved to 29.36%, as compared to 23.91% achieved during the third quarter of 2007 caused by an increase in the average selling price.

Total operating expenses for the three months ended June 30, 2008 were RMB 45.71 million (US$6.66 million), a decrease of 7.79% from RMB 49.58 million (US$6.51 million) in the same period of the prior year. The decrease was mainly due to the effective internal controls over daily operating costs and expenses.

Selling and marketing expenses were RMB 16.82 million (US$2.45 million) for the third quarter of 2008, representing a decrease of 7.95% from RMB 18.27 million (US$2.40 million) for the same period of the last year, which was mainly due to the decrease in advertising expenses. Our marketing focus this year consisted mainly of setting up more effective and cost efficient field demonstration lots, and eliminating our spending on advertising and other media expenditures.

General and administrative expenses of RMB 19.06 million (US$2.78 million) for the third quarter ended June 30, 2008, decreased 4.29% from RMB 19.92 million (US$2.62 million) for the three months ended June 30, 2007 due to an effective control over daily operating costs and expenses, which should continue to take further effect over the next 3 quarters.

Research and development expenses during the quarter were RMB 9.83 million (US$ 1.43 million), as compared with RMB 11.39 million (US$ 1.50 million) for the three months ended June 30, 2007. R&D expenditures decreased slightly this quarter, but it has increased for the nine-month period as a result of the increased build out of our in-house biotechnology center at our Beijing headquarters. We expect to continue building our capabilities in an efficient, cost effective manner.

Income from operations for the third quarter of 2008 amounted to RMB 98.38 million (US$ 14.34 million) compared with an operating income of RMB 59.35 million (US$7.80 million) in the same period in 2007 reflecting a 65.77% increase year-over-year.

Interest expenses for the third quarter of 2008 were RMB10.31 million (US$1.50 million), representing an increase of 145.29 % from RMB 4.20 million (US$0.55 million) for the three months ended June 30, 2007, which was primarily attributable to the inclusion of the interest expenses on the convertible debt of RMB 5.51 million (US$0.80 million) in the third quarter of 2008.

Net income for the third quarter of 2008 rose by 62.98% to RMB 60.12 million (US$ 8.77 million), as compared to net income of RMB 36.89 million (US$4.85 million) in the same period a year ago. Earnings per share on a fully diluted basis were RMB 2.62 (US$0.38), as compared to RMB 1.50 (US$0.20) per diluted share in the same period one year ago, reflecting a 74.67% year-over-year increase.

Balance Sheet

As of June 30, 2008 and September 30, 2007, Origin's balance sheet included cash and cash equivalents of RMB 334.66 million (US$48.79 million) and RMB162.31 million (US$21.66 million), respectively. Investments in US Government Agency bonds amounted to RMB 12.57 million (US$1.83 million) and RMB 133.97 million (US$17.88 million), respectively. Net working capital amounted to RMB 285.96 million (US$ 41.69 million) and RMB 294.98 million (US$39.37 million), respectively. Total shareholders' equity increased to RMB 332.38 million (US$48.46 million) as compared to RMB 296.92 million (US$39.63 million) for September 30, 2007.

Company Update

As the Company moves beyond the 2007 transition year, the average prices, exclusive of scrap sales, have rebounded and increased year-over-year by approximately 6.2%. Volume has also increased 2.2%. In addition to the growth due to the reversal of industry factors, the Company has also streamlined its marketing efforts. The lower sales and marketing expense was due to a focus on more effective on-site demonstration lots for the Company’s customer base, yielding higher average price and volumes. The Company intends to increase its efforts in this regard, by doubling the demonstration lots in FY2008 from 5,000 to 10,000 in FY2009.

Origin also entered into a Notes Repurchase Agreement on July 28, 2008 with Citadel Equity Fund Ltd. providing for the repurchase by the Company from Citadel of a portion of the Company’s outstanding 1% Guaranteed Senior Secured Convertible Notes due 2012. The Note repurchase provides Origin with the opportunity to increase equity shareholder value while providing flexibility to its operations as well as fund its GMO development through internally generated resources.

GMO Pipeline Update

During the quarter, Origin submitted to the Ministry of Agriculture (MOA) its final application and all related documents regarding the Phytase corn product. The Company is hopeful a final decision will be rendered before the end of this year. Upon approval, the product would be able to be sold into the Chinese marketplace. This would mark the first GMO corn product approved for commercialization in China.

Revenue Guidance

Origin expects that total revenues for the year ending September 30, 2008 will approximate US$75 - US$80 million. Net income for the year ending September 30, 2008 will approximate US$0.5 - US$2.0 million.

The net income figure is inclusive of roughly US$ 2.65 million dollars in non-cash interest expense from our convertible debt offering. Excluding this non-cash expense, the adjusted net income range would be US$3.0 to US$4.5 million. The Company plans to release guidance for 2009 by FY08 year end.

WGL ENTERTAINMENT HOLDINGS INCORPORATED (OTC: WEHI)
"Up slightly in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/WEHI.php

WGL Entertainment Holdings, Inc., through its subsidiary WGL Entertainment, is the producer of the WGL Million Dollar Shootout Reality Television Series and several other made-for-TV sports entertainment events scheduled to be produced in 2008 and beyond.

WEHI News:

August 28 - WGL Entertainment Holdings, Inc. Agrees to Dividend Deal

WGL Entertainment Holdings, Inc. (OTC: WEHI) announced that it has agreed in principal to distribute 15,000,000 shares of a publicly traded media company to its shareholders. The shares represent approximately $100,000 at its current value. The media company whom we will identify upon closing will air the WGL Million Dollar Shootout (MDSO) reality television series through its International outlets and represent the MDSO in the U.S. market for a national network airing. At closing, which is expected by the end of next week, a record date will be set for the distribution of the shares.

"This new partnership will bring many synergies to both companies not only in the media environment, but in the pursuit of further mergers and acquisitions. The dividend being paid represents 13.3% of WGL Entertainment Holdings, Inc.'s current market capitalization," said Mike Pagnano, CEO, WGL Entertainment Holdings, Inc. "We continue to work very hard to bring value to our shareholders and appreciation of our PPS. This significant agreement is a Win-Win for all involved."

CELL GENESYS INCORPORATED (NASDAQ: CEGE)
"Up 26.30% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CEGE.php

Cell Genesys, Inc., a biotechnology company, engages in the development and commercialization of biological therapies for patients with cancer. It develops cell-based cancer immunotherapies and oncolytic virus therapies. The company's GVAX cancer Immunotherapies comprise Prostate Cancer, a phase III product for the treatment of prostate cancer; Pancreatic Cancer, a phase II product for pancreatic cancer; and Leukemia, a phase II product for the treatment of acute and chronic myelogenous leukemia, and myelodysplastic syndrome. Its Oncolytic Virus Therapy includes CG0070, a phase I product for the treatment of recurrent bladder cancer. Cell Genesys has alliance with Novartis AG for the development and commercialization of oncolytic virus therapies; research and development collaboration with Medarex, Inc.; and development and commercialization collaboration of GVAX immunotherapy with Takeda Pharmaceutical Company Limited for prostate cancer. The company was founded in 1988 and is headquartered in South San Francisco, California.

CEGE News:

August 27 - Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer

Cell Genesys, Inc. (Nasdaq: CEGE) announced that it has terminated VITAL-2, the second of two Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, which compares GVAX immunotherapy in combination with Taxotere® (docetaxel) to Taxotere plus prednisone in patients with advanced-stage prostate cancer. The Company ended the trial as recommended by its Independent Data Monitoring Committee (IDMC) which, in a routine safety review meeting held this week, observed an imbalance in deaths between the two treatment arms of the study.

To date, VITAL-2 enrolled 408 patients. The IDMC based its recommendation on 114 deaths of which 67 occurred in the GVAX plus Taxotere combination treatment arm and 47 deaths occurred in the Taxotere control arm. At this time, a specific cause for the imbalance in deaths has not been identified and the IDMC reported no new safety issues for GVAX when administered in combination with Taxotere. The Company plans to fully analyze the clinical data from these patients to attempt to understand the potential cause for the higher rate of deaths observed in the GVAX immunotherapy plus Taxotere combination arm, including an assessment of potential imbalances between the two arms of the study such as baseline characteristics and prognostic factors, as well as other treatment variables. In light of the IDMC’s observation with respect to VITAL-2, the Company has requested that the IDMC perform a previously unspecified futility analysis of VITAL-1, the other Phase 3 clinical trial of GVAX immunotherapy for prostate cancer. The Company expects the results of the VITAL-1 futility analysis in approximately one month.

"Patient safety is always our paramount concern and so we have immediately responded to the recommendation of the IDMC. We are currently notifying all participating clinical trial sites and regulatory agencies that enrollment of new patients into VITAL-2 has been suspended as has treatment with GVAX immunotherapy for prostate cancer of patients enrolled in the study," stated Stephen A. Sherwin, M.D., chairman and chief executive officer of Cell Genesys. “Notwithstanding this disappointing outcome, we would like to acknowledge the courage and commitment of the patients and physicians who have participated in this trial.”

Dr. Sherwin continued, “The observation in the VITAL-2 trial is very surprising to us, and we have therefore asked the IDMC to conduct a previously unplanned futility analysis of VITAL-1 in order to determine the overall prospects for our ongoing development program for this product. Moreover, with the cessation of VITAL-2, we expect to make commensurate adjustments to our business operations and we will provide further details regarding this in the near future. As a reminder, the company ended the second quarter of 2008 with $166 million in cash."

VITAL-2 was a multi-center, randomized, controlled Phase 3 clinical trial designed to evaluate the safety and efficacy of GVAX immunotherapy for prostate cancer used in combination with Taxotere chemotherapy compared to the use of Taxotere chemotherapy and prednisone in hormone-refractory prostate cancer (HRPC) patients with metastatic disease who are symptomatic with cancer-related pain. The primary endpoint of the trial was an improvement in survival. VITAL-2 was initiated in June 2005 and to date had enrolled 408 patients at 115 clinical trial sites located in North America and the European Union. VITAL-1, the other Phase 3 clinical trial of GVAX immunotherapy for prostate cancer, is designed to compare GVAX cancer immunotherapy as a monotherapy to Taxotere chemotherapy plus prednisone in earlier stage HRPC patients with metastatic disease who are asymptomatic with respect to cancer-related pain. The primary endpoint of the trial is an improvement in survival. In 2007, the VITAL-1 trial completed enrollment with 626 patients. In January 2008, Cell Genesys announced that the IDMC had completed a pre-planned interim analysis for VITAL-1 and recommended that the study continue, providing no further information to the company other than the recommendation to continue the trial.

ABOUT GVAX IMMUNOTHERAPY FOR PROSTATE CANCER

GVAX immunotherapy for prostate cancer is comprised of two prostate tumor cell lines that have been modified to secrete GM-CSF (granulocyte-macrophage colony-stimulating factor), an immune stimulatory cytokine that plays a key role in stimulating the body's immune response, and then irradiated for safety. GVAX immunotherapy for prostate cancer is designed to be administered through intradermal injections on an outpatient basis.